Phase 2 Trial Assesses c-Abl Inhibitor for Early Parkinson’s
In a landmark clinical advancement poised to reshape the therapeutic landscape of neurodegenerative disorders, researchers have unveiled compelling data on ...
In a landmark clinical advancement poised to reshape the therapeutic landscape of neurodegenerative disorders, researchers have unveiled compelling data on ...
A groundbreaking study from the Broad Institute and Mass General Brigham has unveiled a surprising new avenue for combating Parkinson’s ...
In a groundbreaking study poised to reshape our understanding of Parkinson’s disease at the cellular level, researchers have unveiled the ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine